Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Yepes

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Journal of Cell Science|February 3, 2019
Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminalAriel Diaz, Valerie Jeanneret, Paola Merino, et al.
The American Journal of Pathology|August 25, 2007
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activationXiaohui Zhang, Rohini Polavarapu, Hua She, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 4, 2005
Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activationRohini Polavarapu, Maria Carolina Gongora, Jeffrey A Winkles, et al.
The Journal of Biological Chemistry|May 4, 2018
Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brainPaola Merino, Ariel Diaz, Luis Guillermo Manrique, et al.
The Journal of Clinical Investigation|May 5, 2010
Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampusRamiro Echeverry, Jialing Wu, Woldeab B Haile, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 13, 2018
Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processesAriel Diaz, Paola Merino, Luis G Manrique, et al.
Journal of Neuroinflammation|March 8, 2012
The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous systemRamiro Echeverry, Fang Wu, Woldeab B Haile, et al.
Blood|July 17, 2008
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brainJie An, Chen Zhang, Rohini Polavarapu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 19, 2021
Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrierAriel Diaz, Yena Woo, Cynthia Martin-Jimenez, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2022
Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical NeuronsAriel Diaz, Cynthia Martin-Jimenez, Yena Woo, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Journal of Cell Science|February 3, 2019
Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminalAriel Diaz, Valerie Jeanneret, Paola Merino, et al.
The American Journal of Pathology|August 25, 2007
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activationXiaohui Zhang, Rohini Polavarapu, Hua She, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 4, 2005
Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activationRohini Polavarapu, Maria Carolina Gongora, Jeffrey A Winkles, et al.
The Journal of Biological Chemistry|May 4, 2018
Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brainPaola Merino, Ariel Diaz, Luis Guillermo Manrique, et al.
The Journal of Clinical Investigation|May 5, 2010
Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampusRamiro Echeverry, Jialing Wu, Woldeab B Haile, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 13, 2018
Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processesAriel Diaz, Paola Merino, Luis G Manrique, et al.
Journal of Neuroinflammation|March 8, 2012
The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous systemRamiro Echeverry, Fang Wu, Woldeab B Haile, et al.
Blood|July 17, 2008
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brainJie An, Chen Zhang, Rohini Polavarapu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 19, 2021
Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrierAriel Diaz, Yena Woo, Cynthia Martin-Jimenez, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2022
Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical NeuronsAriel Diaz, Cynthia Martin-Jimenez, Yena Woo, et al.
Pageof 9